Intuitive Surgical Inc(ISRG) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | NDX, S&P 500 | P/E | 40.49 | EPS (ttm) | 8.73 | Insider Own | 0.71% | Shs Outstand | 353.9M | Perf Week | -4.34% |
| Market Cap | 124.79B | Forward P/E | 29.24 | EPS next Y | 11.87% | Insider Trans | -0.79% | Shs Float | 350.8M | Perf Month | -10.2% |
| Enterprise Value | 119.67B | PEG | 1.94 | EPS next Q | 2.64 | Inst Own | 89.6% | Short Float | 2.02% | Perf Quarter | -17.2% |
| Income | 3.14B | P/S | 11.31 | EPS this Y | 20.93% | Inst Trans | 0.16% | Short Ratio | 2.36 | Perf Half Y | -27.29% |
| Sales | 11.03B | P/B | 6.88 | EPS next 5Y | 15.06% | ROA | 15.3% | Short Interest | 7.07M | Perf YTD | -37.63% |
| Book/sh | 51.34 | P/C | 23.79 | EPS past 3/5Y | 29.18% 21.79% | ROE | 17.43% | 52W High | -41.5% ($603.88) | Perf Year | -24.45% |
| Cash/sh | 14.85 | P/FCF | 38.72 | Sales past 3/5Y | 17.39% 18.22% | ROIC | 17.28% | 52W Low | 7.51% ($328.57) | Perf 3Y | 18.45% |
| Dividend Est. | - | EV/EBITDA | 28.59 | EPS Y/Y TTM | 21.06% | Gross Margin | 66.66% | Volatility(W/M) | 3.22% 2.89% | Perf 5Y | -0.96% |
| Dividend TTM | - | EV/Sales | 10.85 | Sales Y/Y TTM | 20.66% | Oper. Margin | 31.28% | ATR (14) | 11.66 | Perf 10Y | 370.14% |
| Dividend Ex-Date | - | Quick Ratio | 3.91 | EPS Q/Q | 26.62% | Profit Margin | 28.45% | RSI (14) | 37.42 | Recom | 1.76 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.96 | Sales Q/Q | 18.54% | SMA20 | -6.34% ($377.15) | Beta | 1.48 | Target Price | $479.86 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/7/16 | SMA50 | -6.76% ($378.85) | Rel Volume | 0.79 | Prev Close | $350.16 |
| Employees | 17021 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 11.5% 2.37% | SMA200 | -23.5% ($461.75) | Avg Volume(3M) | 3.00M | Price | $353.24 |
| IPO | 2000/6/13 | Option/Short | Yes/Yes | Trades | 46012 | Volume | 2,358,886 | Change | 0.88% |
Company
ISRG is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
Intuitive Surgical is a global leader in medical robotics, developing and supplying the da Vinci surgical robot system. Headquartered in Sunnyvale, California, USA, the company was founded in 1995 and has established itself as the global standard in minimally invasive robotic surgery. Its business model is characterized not only by system sales but also by recurring revenue from disposable instruments and services.
Over the past 1 year, on the lower side
42% below its 1-year high.
ISRG makes money exceptionally well
31.28% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +20.9% this year.
Tap to view numbers
But it is not cheap
Trading at 40.5 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 2 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +18.4% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 89.6%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
It is the largest in the industry
Based on market cap of $125B.
FAQ
What kind of company is ISRG?
ISRG belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of ISRG?
The market cap of ISRG is approximately $124.8B, ranking 126 within its sector.
What is the P/E ratio of ISRG?
ISRG has a P/E ratio of approximately 40.5x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ISRG?
ISRG has recorded a 52-week high of $603.88 and a low of $328.57.